Search
Rovadicitinib
go.drugbank.com/drugs/DB21747InvestigationalRovadicitinib is under investigation in clinical trials NCT06682169 and NCT06300320 for the treatment of Chronic Graft-versus-host Disease.
Perifosine
go.drugbank.com/drugs/DB06641InvestigationalPerifosine is a novel alkylphospholipid with antiproliferative properties attributed to protein kinase B inhibition.
TAK-243
go.drugbank.com/drugs/DB15013InvestigationalTAK-243 is under investigation in clinical trial NCT03816319 (TAK-243 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Refractory Myelodysplastic Syndrome or Chronic Myelomonocytic
Calcium sulfate
go.drugbank.com/drugs/DB15533InvestigationalCategories: Compounds used in a research, industrial, or household settingTroclosene
go.drugbank.com/drugs/DB15960InvestigationalCategories: Compounds used in a research, industrial, or household settingLascufloxacin
go.drugbank.com/drugs/DB20002ExperimentalLascufloxacin is a small molecule drug. The usage of the INN stem '-oxacin' in the name indicates that Lascufloxacin is a nalidixic acid derivative antibacterial. … Lascufloxacin has a monoisotopic molecular weight of 439.17 Da.
Categories: Antibacterials for Systemic Use, Antiinfectives for Systemic UseCRx-401
go.drugbank.com/drugs/DB05775ExperimentalIt consists of a low dose of the analgesic diflunisal in conjunction with a modified-release therapeutic dose of bezafibrate, an anti-cholesterol agent. … Unlike other NSAIDs, or non-steroidal anti-inflammatory drugs, the dose of diflunisal in CRx-401 has demonstrated in preclinical studies the ability to synergistically enhance the anti-diabetic effects
Lasalocid
go.drugbank.com/drugs/DB11423ExperimentalVet approvedLasalocid is an agent that presents antibacterial and coccidiostat activities. It is produced by strains of _Streptomyces lasaliensis_.
Categories: Compounds used in a research, industrial, or household settingSuccinobucol
go.drugbank.com/drugs/DB05399InvestigationalAGI-1067, is a novel small molecule with anti-oxidant and anti-inflammatory properties that was discovered by AtheroGenics and designed to treat atherosclerosis of the blood vessels of the heart, or coronary
Penimepicycline
go.drugbank.com/drugs/DB13264ExperimentalPenimepicycline is a tetracycline-class antibiotic. It is mentioned on List A produced by the Government of Canada, which is a list of antimicrobial active pharmaceutical ingredients [L2791]. … In the classification of the active ingredients included on this list, the classification document states that tetracycline class antibiotics are of medium importance, and are used in humans [L5620].
Categories: Antibacterials for Systemic Use, Antiinfectives for Systemic Use